The mechanisms that regulate Th17 differentiation in the context of CLL are unknown, although the Th17-inducing cytokines IL-1β and IL-6 are elevated in a subset of CLL patients with good prognosis [26] and presumably drive Th17 differentiation in that population. This evidence concerns the gene IL1B and B-cell chronic lymphocytic leukemia.